MLYS (STOCKS)
Mineralys Therapeutics, Inc. Common Stock
$29.780000
-1.290000 (-4.15%)
Prev close: $31.070000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jon Congleton
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,459.70M
- Employees
- 51
- P/E (TTM)
- -10.07
- P/B (TTM)
- 4.08
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
8
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.52 | $-0.63 | +0.1124 | +17.77% |
|
Jun 2025 (Q2)
|
$-0.66 | $-0.73 | +0.0744 | +10.13% |
|
Mar 2025 (Q1)
|
$-0.79 | $-1.00 | +0.2116 | +21.13% |
|
Dec 2024 (Q4)
|
$-0.98 | $-1.10 | +0.1187 | +10.80% |
Financial Statements
| Assets | $599.95M |
| Current Assets | $599.80M |
| Noncurrent Assets | $151.00K |
| Fixed Assets | $7.00K |
| Other Non-current Assets | $144.00K |
| Liabilities | $23.52M |
| Current Liabilities | $23.52M |
| Accounts Payable | $1.12M |
| Other Current Liabilities | $22.40M |
| Noncurrent Liabilities | $0.00 |
| Equity | $576.43M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $576.43M |
| Liabilities And Equity | $599.95M |